IONS

Ionis Pharmaceuticals, Inc. Common Stock

42.57

USD

-0.95

-2.18%

Nov 02, 10:27 UTC -5

Open

Ionis Pharmaceuticals, Inc. Common Stock (IONS) Earnings

IONS Earnings Reports

Positive Surprise Ratio

IONS beat 30 of 43 last estimates.

70%

Next Report

Date of Next Report

Feb 23, 2027

Estimate for Q4 26 (Revenue/ EPS)

$227.25M

-$1.11

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

+11.94%

-21.28%

Ionis Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Oct 27, 2026, IONS reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -1.23 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 185.76 million, with a --% difference.

Looking ahead to Q4 26, 8 analysts forecast an EPS of -1.11 USD, with revenue projected to reach 227.25 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Indivior Pharmaceuticals, Inc. Common Stock

Report Date

Oct 29, 2026 For Q3 26

Estimate

$1.14

Actual

$1.32

Surprise

+15.65%

Aurinia Pharmaceuticals Inc

Report Date

Oct 30, 2026 For Q3 26

Estimate

$0.22

Actual

$0.23

Surprise

+2.50%

Takeda Pharmaceutical Company Limited - ADR

Report Date

Oct 29, 2026 For Q2 27

Estimate

$46.66

Actual

$80.55

Surprise

+72.64%

OmniAb, Inc. Common Stock

Report Date

Oct 30, 2026 For Q3 26

Estimate

-$0.12

Actual

-$0.12

Surprise

+3.54%

FAQ

What were Ionis Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Ionis Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Ionis Pharmaceuticals, Inc. Common Stock's Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Ionis Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 23, 2027.

What are the forecasts for Ionis Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 8 analysts, Ionis Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$1.11 and revenue of $227.25M for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.